BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25042743)

  • 1. Gain-of-function mutations in signal transducer and activator of transcription 1 (STAT1): chronic mucocutaneous candidiasis accompanied by enamel defects and delayed dental shedding.
    Frans G; Moens L; Schaballie H; Van Eyck L; Borgers H; Wuyts M; Dillaerts D; Vermeulen E; Dooley J; Grimbacher B; Cant A; Declerck D; Peumans M; Renard M; De Boeck K; Hoffman I; François I; Liston A; Claessens F; Bossuyt X; Meyts I
    J Allergy Clin Immunol; 2014 Nov; 134(5):1209-13.e6. PubMed ID: 25042743
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation.
    Higgins E; Al Shehri T; McAleer MA; Conlon N; Feighery C; Lilic D; Irvine AD
    J Allergy Clin Immunol; 2015 Feb; 135(2):551-3. PubMed ID: 25662309
    [No Abstract]   [Full Text] [Related]  

  • 3. Autosomal dominant cases of chronic mucocutaneous candidiasis segregates with mutations of signal transducer and activator of transcription 1, but not of Toll-like receptor 3.
    Al Rushood M; McCusker C; Mazer B; Alizadehfar R; Grimbacher B; Depner M; Ben-Shoshan M
    J Pediatr; 2013 Jul; 163(1):277-9. PubMed ID: 23541088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
    Tabellini G; Vairo D; Scomodon O; Tamassia N; Ferraro RM; Patrizi O; Gasperini S; Soresina A; Giardino G; Pignata C; Lougaris V; Plebani A; Dotta L; Cassatella MA; Parolini S; Badolato R
    J Allergy Clin Immunol; 2017 Aug; 140(2):553-564.e4. PubMed ID: 28069426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC).
    Zheng J; van de Veerdonk FL; Crossland KL; Smeekens SP; Chan CM; Al Shehri T; Abinun M; Gennery AR; Mann J; Lendrem DW; Netea MG; Rowan AD; Lilic D
    Eur J Immunol; 2015 Oct; 45(10):2834-46. PubMed ID: 26255980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gain-of-function mutation of STAT1: A novel genetic factor contributing to chronic mucocutaneous candidiasis.
    Eslami N; Tavakol M; Mesdaghi M; Gharegozlou M; Casanova JL; Puel A; Okada S; Arshi S; Bemanian MH; Fallahpour M; Molatefi R; Seif F; Zoghi S; Rezaei N; Nabavi M
    Acta Microbiol Immunol Hung; 2017 Jun; 64(2):191-201. PubMed ID: 28597685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT1 Mutations in Chronic Mucocutaneous Candidiasis Diagnosed in an Adult.
    Andou M; Tominaga M; Nishikomori R; Gotoh K; Komatsu N; Matsuoka M; Kawayama T; Hoshino T
    Intern Med; 2024 May; 63(9):1269-1271. PubMed ID: 37779067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation.
    Bloomfield M; Kanderová V; Paračková Z; Vrabcová P; Svatoň M; Froňková E; Fejtková M; Zachová R; Rataj M; Zentsová I; Milota T; Klocperk A; Kalina T; Šedivá A
    J Clin Immunol; 2018 Jul; 38(5):589-601. PubMed ID: 29934865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baricitinib treatment in a patient with a gain-of-function mutation in signal transducer and activator of transcription 1 (STAT1).
    Meesilpavikkai K; Dik WA; Schrijver B; Nagtzaam NMA; Posthumus-van Sluijs SJ; van Hagen PM; Dalm VASH
    J Allergy Clin Immunol; 2018 Jul; 142(1):328-330.e2. PubMed ID: 29729898
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic mucocutaneous candidiasis due to gain-of-function mutation in STAT1.
    Carey B; Lambourne J; Porter S; Hodgson T
    Oral Dis; 2019 Apr; 25(3):684-692. PubMed ID: 29702748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human STAT1 gain-of-function iPSC line from a patient suffering from chronic mucocutaneous candidiasis.
    Haake K; Wüstefeld T; Merkert S; Lüttge D; Göhring G; Auber B; Baumann U; Lachmann N
    Stem Cell Res; 2020 Mar; 43():101713. PubMed ID: 32000109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic mucocutaneous candidiasis associated with an SH2 domain gain-of-function mutation that enhances STAT1 phosphorylation.
    Sobh A; Chou J; Schneider L; Geha RS; Massaad MJ
    J Allergy Clin Immunol; 2016 Jul; 138(1):297-299. PubMed ID: 26948078
    [No Abstract]   [Full Text] [Related]  

  • 13. Autosomal-dominant chronic mucocutaneous candidiasis with STAT1-mutation can be complicated with chronic active hepatitis and hypothyroidism.
    Hori T; Ohnishi H; Teramoto T; Tsubouchi K; Naiki T; Hirose Y; Ohara O; Seishima M; Kaneko H; Fukao T; Kondo N
    J Clin Immunol; 2012 Dec; 32(6):1213-20. PubMed ID: 22847544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Report: Disseminated
    Chen K; Tan J; Qian S; Wu S; Chen Q
    Front Immunol; 2021; 12():682350. PubMed ID: 34421897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1.
    Depner M; Fuchs S; Raabe J; Frede N; Glocker C; Doffinger R; Gkrania-Klotsas E; Kumararatne D; Atkinson TP; Schroeder HW; Niehues T; Dückers G; Stray-Pedersen A; Baumann U; Schmidt R; Franco JL; Orrego J; Ben-Shoshan M; McCusker C; Jacob CM; Carneiro-Sampaio M; Devlin LA; Edgar JD; Henderson P; Russell RK; Skytte AB; Seneviratne SL; Wanders J; Stauss H; Meyts I; Moens L; Jesenak M; Kobbe R; Borte S; Borte M; Wright DA; Hagin D; Torgerson TR; Grimbacher B
    J Clin Immunol; 2016 Jan; 36(1):73-84. PubMed ID: 26604104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two novel gain-of-function mutations of STAT1 responsible for chronic mucocutaneous candidiasis disease: impaired production of IL-17A and IL-22, and the presence of anti-IL-17F autoantibody.
    Yamazaki Y; Yamada M; Kawai T; Morio T; Onodera M; Ueki M; Watanabe N; Takada H; Takezaki S; Chida N; Kobayashi I; Ariga T
    J Immunol; 2014 Nov; 193(10):4880-7. PubMed ID: 25288569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Candida infection, bronchiectasis, immunoglobulin abnormalities, and stunting: a case report of a natural mutation of STAT1 (c.986C>G) in an adolescent male.
    Yu Y; Xu F; Shen H; Wu J
    BMC Infect Dis; 2021 Jan; 21(1):38. PubMed ID: 33413180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A Case of Chronic Mucocutaneous Candidiasis Associated with STAT1 Mutation].
    Miura T; Nakazato N; Nagata K; Shinohara N
    Nihon Naika Gakkai Zasshi; 2015 Aug; 104(8):1646-51. PubMed ID: 30160848
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrent inflammatory aortic aneurysms in chronic mucocutaneous candidiasis with a gain-of-function STAT1 mutation.
    Tanimura M; Dohi K; Hirayama M; Sato Y; Sugiura E; Nakajima H; Kanemitsu S; Toyoda H; Yamada N; Masuya M; Imanaka-Yoshida K; Shimpo H; Azuma E; Ito M
    Int J Cardiol; 2015 Oct; 196():88-90. PubMed ID: 26080282
    [No Abstract]   [Full Text] [Related]  

  • 20. Case Report: A New Gain-of-Function Mutation of
    Martinot M; Korganow AS; Wald M; Second J; Birckel E; Mahé A; Souply L; Mohseni-Zadeh M; Droy L; Tarabeux J; Okada S; Migaud M; Puel A; Guffroy A
    Front Immunol; 2021; 12():760019. PubMed ID: 34987506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.